Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow Print PDF (155K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (33)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Goppelt, A
Right arrow Articles by Meisterernst, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goppelt, A
Right arrow Articles by Meisterernst, M
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1996 Oxford University Press 4450-4456

Footnote

Characterization of the basal inhibitor of class II transcription NC2 from Saccharomyces cerevisiae

Characterization of the basal inhibitor of class II transcription NC2 from Saccharomyces cerevisiae Andreas Goppelt and Michael Meisterernst*

Laboratorium für Molekulare Biologie-Genzentrum der Ludwig-Maximilians-Universität München, Feodor-Lynenstraße 25, 81377 München , Germany

Received August 15, 1996; Revised and Accepted October 1, 1996

ABSTRACT

Human NC2 utilizes a unique mechanism of repression of transcription by associating with TBP and inhibition of preinitiation complex formation. Here we have cloned two genes from Saccharomyces cerevisiae and functionally characterized them as yeast NC2. We show that yeast NC2 binds to TBP as a heterodimer and represses RNA polymerase II transcription during assembly of the preinitiation complex. Yeast NC2 is highly homologous to its human counterpart within histone fold domains. C-Terminal regions previously discussed to be important for repression in man are in part not conserved. The human [alpha] but not the [beta] subunit efficiently heterodimerizes and represses transcription in combination with the corresponding yeast subunit. Yeast and human NC2 inhibit transcription in the presence of yeast and human TBP. However, repression is optimal within one species. The N-terminus of human TBP supports repression of transcription by human but not by yeast NC2.

INTRODUCTION

Transcription by RNA polymerase II in the eukaryotic cell is regulated by the complex interplay of positive and negative regulators. Transcriptional inhibitors have evolved to utilize a variety of repression mechanisms (reviewed in 1 ). Many of the repressors are site-specific DNA binding proteins that control the activity of specific genes. Some examples have been reported that regulate basal promoter activity by directly targeting the basal transcription machinery. For example, ADI/Mot1 releases the TATA binding protein (TBP) from the promoter ( 2 ). Another example is provided by negative cofactor 2 (NC2) ( 3 ). Human NC2 was recently purified and cloned ( 4 , 5 ). NC2 is a heterodimer consisting of NC2[alpha]/DRAP1 and NC2[beta]/Dr1 ( 6 ). NC2 binds to TBP and inhibits binding of both TFIIA and TFIIB. NC2 contact points on TBP have been mapped to a basic region within the core of TBP ( 7 ) that overlaps with the binding site of TFIIA ( 8 , 9 ), arguing for a steric exclusion of TFIIA and NC2. The precise mechanism of TFIIB exclusion is not yet understood. Surprisingly, the TBP-TFIIB interface lies opposite the interaction surface of TBP with NC2 ( 10 , 11 ). However, it is possible that inhibition of TFIIB assembly also depends on conformational changes in the promoter structure induced by NC2.

Here, we reasoned that NC2 function should be conserved in different species, since the region of TBP that binds to human NC2 is highly conserved among species in its primary sequence and structure ( 12 ). We report cloning of the NC2 subunits from Saccharomyces cerevisiae and characterize the recombinant proteins in an in vitro system reconstituted with human components that allowed the interchange of human and yeast subunits.

MATERIALS AND METHODS

Materials

Restriction enzymes Nde I and Bam HI and Vent DNA polymerase were obtained from New England Biolabs (Schwalbach, Germany). Bovine serum albumin solution (20 mg/ml) was from Boehringer Mannheim (Mannheim, Germany). All chemicals were purchased either from Sigma (Deisenhofen, Germany) or Merck (Darmstadt, Germany). Oligonucleotides were synthesized by Eurogentec (Belgium). Ni-NTA-agarose was purchased from Diagen (Hilden, Germany), heparin-Sepharose from Pharmacia (Freiburg, Germany) and cyanogen bromide-activated Sepharose 4B from Sigma (Deisenhofen, Germany).

Cloning of the yeast NC2 subunits

Aliquots of 55 ng yeast cDNA library (a gift of J.Regenbogen, Ludwig-Maximilians-Universität München, Germany) or 10 ng genomic yeast DNA were employed in a standard PCR containing 200 pmol forward primer and 200 pmol reverse primer in a final volume of 0.1 ml. Oligonucleotide primers for amplification of yNC2[alpha] were the forward primer yNC2[alpha]UP, 5'-CCATGGAACAT ATGGCAGATCAAGTACC -3', and the reverse primer yNC2[alpha]DOWN, 5'-ATCCGGATCC TCAGGCACTCTCTTCC -3' (underlined nucleotides designate the coding region in each primer). The N-terminal deletion mutant yNC2[alpha][Delta]31 was constructed by PCR with the forward primer yNC2[alpha][Delta]UP, 5'-ccatggaacat atgggtaccaactcgaa -3', and yNC2[alpha]- DOWN. yNC2[beta] was amplified with the primer set yNC2[beta]UP, 5'-CAGGAATTCCAT ATGGCTGGAGACTCCGA -3', and yNC2[beta]DOWN, 5'-CTTGGATCC TCAAGAAGAATCCTCCG -3'. The reaction products were digested with Nde I and Bam HI and cloned into the expression plasmid pET15b (Novagen, Madison, WI) digested with the appropriate restriction enzymes. Expression and purification of recombinant proteins. NC2 subunits were expressed in Escherichia coli strain BL21(DE3) (Novagen, Madison, WI). Both yeast and human NC2[beta], yNC2[alpha] and yNC2[alpha][Delta]31 were purified essentially to homogeneity via denaturing Ni-NTA-agarose affinity chromatography following the manufacturer's instructions. Purification of hNC2[alpha], human full-length and core TBP and yeast TBP has been described ( 4 , 13 ).

Gel retardation analysis

Electrophoretic mobility shift assays (EMSAs) were carried out as described ( 4 ). Reactions contained 4 ng hNC2[alpha], 30 ng hNC2[beta]/Dr1, 30 ng yNC2[alpha], 30 ng yNC2[alpha][Delta]31, 30 ng yNC2[beta] and 10 ng recombinant yeast TBP. Aliquots of 50 fmol of a 90 bp end-labeled DNA fragment containing the HIV promoter TATA box were used as probe. EMSAs were analyzed in 5% (50:1) 0.5* Tris-borate-EDTA polyacrylamide gels containing 5% (v/v) glycerol and 2 mM MgCl 2 .

Protein binding assay

Human and yeast NC2[beta] and BSA as a control were covalently immobilized on BrCN Sepharose. Briefly, the beads were washed with 1 mM HCl before coupling and equilibrated in coupling buffer (0.1 M NaHCO 3 , pH 8.3, containing 0.5 M NaCl). The ligands were dialyzed to coupling buffer and incubated with the beads at a final concentration of 1 mg/ml. Excess ligand was washed away with coupling buffer and the remaining active groups were blocked with 0.1 M Tris-HCl, pH 8.0. Samples of 10 [mu]g human or yeast NC2[alpha] were incubated with 10 [mu]l affinity beads in a final volume of 100 [mu]l under transcription conditions for 1 h at room temperature. After extensive washing the beads were boiled in Laemmli buffer and subjected to SDS-PAGE.

In vitro transcription assay

In vitro transcription reactions were carried out with the Sma I-linearized HIV core promoter pMRG5 as described ( 20 ). Reactions contained the full set of general transcription factors, including recombinant TFIIA (co-renatured and purified [alpha][beta] and [gamma] subunits), TFIIB, TBP, TFIIE, TFIIF, partially purified TFIIH and RNA polymerase II. In preincubation experiments NC2 subunits were added either before or after 30 min incubation of the general factors with the template at 30oC. Quantitation of the transcripts was performed on an Instant Imager (Canberra Packard).

Computational analyses

Database searches were performed with the Wisconsin Sequence Analysis Package and included the programs FASTA, BLAST and BESTFIT.

RESULTS

Cloning of NC2 subunits from the yeast S.cerevisiae

In order to identify yeast homologs of human NC2 we performed a computer search of the non-redundant NCBI protein database with the human NC2 sequences. Two open reading frames (ORFs) shared significant homology with hNC2 and were designated yNC2[alpha] and yNC2[beta] respectively ( 4 ). The gene for the yNC2[beta] subunit contained an intron of 92 bp (Fig. 1 B). Here, we isolated the corresponding cDNAs encoding the putative NC2 subunits (Fig. 1 A and B). The ORF of yNC2[alpha] encodes a protein of 142 amino acids with a calculated molecular mass of 15.5 kDa, while yNC2[beta] is comprised of 146 amino acids with a calculated molecular mass of 16.6 kDa. Both yeast NC2 subunits contain multiple potential target sites for protein kinases (Fig. 1 A and B). These could be important for yeast NC2 activity, as it has been demonstrated that phosphorylation of human NC2 by casein kinase II (CKII) increases the specificity of NC2 for TBP-promoter complexes ( 10 ).


Figure 1 . Sequences of the yeast NC2 homologs. Potential phosphorylation sites in yeast NC2[alpha] (yNC2[alpha]) and yeast NC2[beta] (yNC2[beta]) for casein kinase II (primary and secondary CKII), protein kinase A (PKA), protein kinase C (PKC) and tyrosine kinase are indicated by symbols. ( A ) Sequence of yNC2[alpha] (ORF YER159c on chromosome V, GenBank accession no. U18917). ( B ) Sequence of yNC2[beta] (ORF D9509.16 on chromosome IV, GenBank accession no. U32274) with a 92 bp intron. The donor site, the downstream branch point and the acceptor site of the intron are underlined. ( C ) Comparison of human and yeast NC2[alpha] sequences. The histone fold domain is boxed. The positions of the three core helices which are set apart by [beta]-strands and form the histone fold are indicated by solid lines. Comparison with the crystal structure of histone H2A reveals that helix III in NC2[alpha] actually extends outside the histone fold, as indicated by a dashed line. ( D ) Comparison of human and yeast NC2[beta]/Dr1 sequences. The boxed region corresponds to the histone fold. ( E ) Schematic drawing of human and yeast NC2 subunits. The position of the histone fold and the FDFL motif, proline-rich (pro-rich), basic, acidic and glutamine/alanine-rich (Q/A-rich) regions are indicated.

Comparison of human and yeast NC2 subunits

Alignment of the putative yeast NC2 subunits with their human counterparts revealed striking conservation of the histone fold, a region which is conserved in all four histones and reconstitutes the structured region of the nucleosome ( 14 ). The histone fold motif consists of a long central [alpha]-helix flanked on each side by a short [alpha]-helix set apart from the central helix by [beta]-strands.

The human and the yeast [alpha] subunit share 41.9% identity and 66.7% similarity in amino acids 7-100 of hNC2[alpha], which encompasses the entire histone fold. Yeast NC2[alpha] is much smaller than hNC2[alpha], although it contains an additional N-terminal region of 54 amino acids. However, it lacks essentially the entire C-terminal region of hNC2[alpha]. The homologous region to hNC2[alpha] includes residues 48-56 of yNC2[alpha], which are predicted to be part of helix I of the histone fold, but which are not conserved in DRAP1 ( 5 ). Homologies in the [alpha] subunits also include a short hydrophobic motif located in the extended helix III, which we term the FDFL box (Fig. 1 C). Both human and yeast NC2 are also highly related to components of the CCAAT box binding factor CBF (also termed NF-Y or CP1). Both the histone fold and the FDFL box are conserved in two subunits of CBF, the CBF-C protein and the corresponding yeast homolog, the HAP5 protein.

The [beta] subunits share 41.3% identity and 62.7% similarity in a region spanning amino acids 5-130 of hNC2[beta]/Dr1 (Fig. 1 D). This region again includes the histone fold motif and extends to a conserved acidic stretch between amino acids 115 and 126 of hNC2[beta]/Dr1 with the sequence EEELLRQQEELF. This acidic stretch is also partly conserved in a putative NC2[beta]/Dr1 protein from Arabidopsis thaliana ( 15 ) and in one subunit of CBF, the CBF-A protein. No function, however, has been assigned to this region so far. The glutamine/alanine-rich region which has been characterized as the repression domain in hNC2[beta]/Dr1 ( 16 ) is not present in yeast NC2[beta] (Fig. 1 E).

In addition to conservation of the histone fold domain and the FDFL box, the [alpha] subunits display a similar overall charge and charge distribution. The histone fold domains of hNC2[alpha] and yNC2[alpha] are basic, whereas the entire polypeptides are acidic. Positive charges in the histone fold may provide an explanation for the observation that the [alpha] subunit non-specifically contacts DNA ( 4 ). In the case of the [beta] subunits the histone fold domains and the full-length proteins possess an acidic isoelectric point.

Interchangeability of yeast and human NC2 subunits

Escherichia coli -expressed and purified NC2 polypeptides were analyzed for their capability to form complexes with DNA and TBP. As in the case of human NC2, each yeast NC2 subunit alone failed to form stable complexes with promoter DNA and TBP (Fig. 2 , lane 3, and data not shown). In contrast, a combination of yNC2[alpha] and yNC2[beta] efficiently formed yNC2-yTBP-DNA complexes (Fig. 2 , lane 4). Thus, both hNC2 and yNC2 are heterodimers that form quarternary complexes with DNA and TBP. The heterodimer of yeast NC2[beta] and human NC2[alpha] (lane 2) but not yeast NC2[alpha] and human NC2[beta]/Dr1 (lane 3) bound to TBP. Yeast NC2-yTBP complexes multimerize on promoter-bound TBP when longer DNA fragments are used as a probe, as has been reported for human NC2-TBP complexes (lanes 1 and 4 and data not shown).


Figure 2 . EMSA showing binding of combinations of human and yeast NC2 subunits to TBP-DNA complexes. Positions of NC2-TBP-promoter complexes are indicated by arrows. The experiment was performed with a 90 bp DNA fragment containing the HIV promoter as probe.The position of the free probe is indicated (DNA). Reactions contain recombinant yeast TBP and combinations of human and yeast NC2 subunits. yNC2[alpha][Delta]31 denotes a deletion mutant of yNC2[alpha] where the first 31 N-terminal amino acids are truncated, as given in Materials and Methods.

The deletion of 31 N-terminal amino acids of yeast NC2[alpha] which are not conserved between yeast and man neither impaired binding to TBP nor multimerization of TBP-NC2 complexes (data not shown). N-Terminal sequences of yeast NC2[alpha] are not responsible for inhibition of heterodimerization with human NC2[beta]/Dr1, as this deletion mutant (yNC2[alpha][Delta]31) did not form stable complexes with human NC2[beta]/Dr1 on promoter-bound yTBP (Fig. 2 , lane 5). To analyze whether the incompatibility of yeast NC2[alpha] and human NC2[beta]/Dr1 was caused by a defect in dimerization, we checked binding of the heterologous NC2[alpha] subunits using the immobilized NC2[beta] proteins as affinity columns.

Whereas human NC2[alpha] was retained in equimolar amounts on the human and yeast NC2[beta] columns, only ~10% of yeast NC2[alpha] bound to human NC2[beta]/Dr1 when compared with yeast NC2[beta] (Fig. 3 , lane 4 versus 5). This binding was specific, as yeast NC2[alpha] did not bind to a BSA mock column and, vice versa, the BSA present in the load (lane 10) was not retained on the yeast NC2[beta] column.


Figure 3 . Silver stain of a SDS-polyacrylamide gel showing association of human and yeast NC2 subunits on immobilized NC2[beta] columns. M, molecular weight standard (in kDa). Human NC2[alpha] eluates from human NC2[beta] and yeast NC2[beta] affinity columns (lanes 2 and 3), bands migrating below the 31 kDa marker are C-terminal breakdown products of hNC2[alpha]. Yeast NC2[alpha] eluates from human NC2[beta] and yeast NC2[beta] affinity columns (lanes 4 and 5) and from a BSA mock column (lane 6). Lanes 7 and 8, human and yeast NC2[beta] used for the preparation of the affinity columns. Lanes 9 and 10, load of the affinity columns; lane 9, partially purified human NC2[alpha]; lane 10, yeast NC2[alpha] and BSA.

Thus we conclude that the inefficient formation of an active NC2 complex between yeast NC2[alpha] and human NC2[beta] is at least in part due to inefficient heterodimerization of these subunits.

Functional analysis

The evolutionary conservation of the repressor NC2 was further underscored through analysis of recombinant proteins in a highly purified in vitro transcription system. Yeast NC2 efficiently inhibited transcription of a given model promoter (Fig. 4 B, lane 3 versus 6), demonstrating that the yeast polypeptides are a potent repressor of class II transcription. The individual subunits alone did not affect transcription (lane 3 versus lanes 1 and 2), which shows that heterodimerization of yNC2 subunits is required for efficient repression of transcription. When individual subunits were exchanged between yeast and man, yNC2[beta] could fully substitute for its human counterpart (lane 4 versus lane 5). In contrast, yNC2[alpha] and hNC2[beta]/Dr1 repressed transcription far less efficiently (lane 3 versus lane 7), which is consistent with the DNA and the protein binding analysis.


Figure 4 . Analysis of recombinant human and yeast NC2 in a highly purified in vitro transcription system. All reactions contain Sma I-linearized HIV core promoter MRG5 (13) and pdGdC as non-specific competitor DNA. The experiments in (A) and (B) were performed with recombinant human TBP. ( A ) Analysis of NC2 effects before and after formation of the preinitiation complex. ( B ) Combinations of recombinant and purified NC2 subunits from S.cerevisiae and man were tested for their capacity to repress transcription in vitro . ( C ) Effects of recombinant human and yeast NC2 in transcription systems. (Top) Bar graph representing the transcription activity of transcription reactions containing 3 ng either recombinant yeast TBP (yTBP, lanes 1-3), human TBP (hTBP, lanes 4-6) or the human core TBP (hcTBP, lanes 7-9). The activities of basal transcription reactions in the absence of repressor (lanes 1, 4 and 7) were arbitrarily set to 100%. The transcripts were quantified on an Instant Imager (Canberra Packard). (Bottom) Autoradiograph of RNA transcripts from transcription reactions quantified in the bar graph above.

Repression of transcription by combinations of human and yeast NC2 subunits correlated with the ability to prevent TFIIB from binding to TBP-promoter complexes (data not shown), as described earlier for hNC2 ( 4 ). In agreement with the model that NC2 primarily acts on preinitiation complex formation, preincubation of the general factors with the template abrogated repression by NC2 (Fig. 4 A, lane 2 versus lane 3).

Both human and yeast NC2 were capable of inhibiting transcription in the presence of human full-length TBP, human core TBP and yeast TBP, although repression of transcription is most effective within the same species (Fig. 4 C, lanes 2 and 3 versus 5 and 6). As the origin of TBP clearly influenced function of NC2, we reasoned that the differential behaviour might be due to the N-terminal domain of TBP, which is not conserved between species. Human NC2 inhibited transcription 6-fold more efficiently in the presence of full-length hTBP than the core of hTBP (Fig. 4 C, lane 5 versus lane 8), indicating that the N-terminus of hTBP enhances the function of hNC2. On the other hand, repression of transciption by yeast NC2 was more pronounced when the N-terminus of hTBP was absent (lane 6 versus 9). In summary, the N-terminus of TBP supports the function of NC2 provided that both are compatible (e.g. originate from the same species).

DISCUSSION

In this study we have identified the homolog of a human repressor of class II transcription, NC2, in the yeast S.cerevisiae. Yeast NC2 exhibits all the characteristics attributed to the human factor. Yeast NC2 is a basal repressor of RNA polymerase II transcription in vitro and consists of two subunits which form quarternary complexes with TBP and DNA. The yeast NC2 sequences are highly conserved between yeast and man, pointing to an evolutionarily important role of NC2. This is also reflected in that both NC2 subunits are essential for yeast viability (R.A.Young, personal communication).

The comparison of the human and yeast NC2 proteins is an evolutionary saturating mutagenesis study, which reveals important regions and amino acids in detail. This study contains several new findings regarding the repressor NC2. NC2 contains a highly conserved core, which consists of the histone fold domains and comprises two regions (the FDFL motif of NC2[alpha] and the acidic region of NC2[beta]) which have not yet been characterized.

The highest degree of homology is found in the histone fold domains. In the histone proteins it serves as an architectural motif utilized in protein dimerization and DNA compaction ( 17 - 19 , 20 ). The homology beween the NC2 [alpha] subunits is restricted almost exclusively to the histone fold. Deletion of N-terminal sequences of yNC2[alpha], leaving the histone fold intact, did not affect its ability to interact with TBP-promoter complexes. The homology between the [beta] subunits extends beyond the histone fold and includes the acidic region. The region between amino acids 80 and 100 of hNC2[beta]/Dr1, however, which has previously been characterized as the TBP binding domain ( 5 , 16 ), is not conserved between yeast and man. Also, our experiments do not support a role in TBP binding, as heterodimers consisting of hNC2[alpha] and hNC2[beta]/Dr1(1-83), which lack this region, efficiently bound to hTBP or yTBP and DNA in vitro ( 4 ; data not shown). The glutamine/alanine-rich region of hNC2[beta]/Dr1 is also not present in yeast. We have previously demonstrated that repression of transcription requires the glutamine/alanine-rich region of hNC2[beta]/Dr1 in the presence of the human TFIID complex but not in the absence of TAFs ( 4 ). This may indicate that the interplay of NC2 and TAFs in yeast differs from that in man. In addition to the TAFs, components of the RNA polymerase II (Pol II) holoenzyme ( 21 , 22 ) which are associated with the C-terminal domain of the largest Pol II subunit counteract NC2. Young and colleagues isolated yeast NC2[alpha] as a functional antagonist of SRB4 in vivo , which is a constituent of the Pol II holoenzyme and characterized yeast NC2 as a global repressor of class II transcription (R.A.Young, personal communication).

Yeast and human NC2 are interchangeable as entities in in vitro transcription. Interestingly, the N-terminus of TBP modulates the function of NC2. Repression of transcription was most pronounced when NC2 and TBP originated from the same species. The presence of the N-terminal domain of human TBP enhanced the function of human NC2, which provides the first positive function for this domain. Initially it was proposed that the N-terminus of human TBP was essential for Sp1-dependent transcription in vitro ( 28 ). Berk and colleagues, however, showed that functional holo-TFIID, which mediated transcriptional activation in vitro (e.g. by Sp1), could be purified from a cell line stably expressing only the core domain of human TBP ( 23 ) or the core domain of yeast TBP ( 24 ).

Mixing experiments of human and yeast NC2 subunits revealed that at least the [beta] subunits can efficiently replace each other in function, whereas a combination of yeast NC2[alpha] and human NC2[beta]/Dr1 failed to bind to TBP-DNA complexes and had little effect on transcription, which is at least in part due to inefficient subunit association. Another example for a sucessful interchange of a transcription factor between these species is provided by TBP (see Fig. 4 C; reviewed in 12 ). Functional exchange of TBP with regard to response to acidic activators in vitro has been reported, although human TBP failed to support yeast cell growth ( 25 ). Examples of other transcription factors that can be exchanged between yeast and man include TFIIA ( 26 - 28 ), subunits of the human CCAAT binding factor CP1 and the yeast HAP2-HAP3 complex ( 7 ). The latter example is intriguing, as CCAAT binding factors are also thought to contain heterodimeric histone folds ( 29 , 3 0) and show the highest degree of homology to NC2.

Other reports describe exchanges between species that are more evolutionarily linked, as exemplified by the yeasts S.cerevisiae and Schizosaccharomyces pombe or the fruit fly Drosophila melanogaster and man. Exchange of general transcription factors of S.cerevisiae and S.pombe revealed that three components, counterparts of human TFIIB, TFIIE and Pol II, could not be exchanged individually but could be swapped in the pairs TFIIE-TFIIH and TFIIB-Pol II, demonstrating functional interactions between the components of these pairs ( 22 ). The general transcription factor TFIIB can be exchanged from D.melanogaster to man (35). In the case of the yeast activator SWI2/SNF2, the D.melanogaster homolog could functionally replace the S.cerevisiae but not the Homo sapiens protein. Chimeric proteins composed of the ATPase domains of D.melanogaster brahma and SWI2 rescued the slow growth phenotype of swi - cells, whereas the fusion of SWI2 with the corresponding domain of the highly homologous human ISWI protein failed to do so ( 31 ).

The low incidence of cases where interchange of factors from man to the yeast S.cerevisiae , representing two of the most divergent species of the eukaryotic kingdom, was possible indicates a stringently conserved function for NC2 in regulating transcription. Further experiments will have to show how specificity within one system is maintained, given the rising number of histone fold proteins in the cell, ranging from general transcription factors ( 32 , 3 3 ) to activators of transcription ( 29 , 3 0).

Acknowledgements

We thank Ellen L.Gadbois and Richard A.Young for sharing results prior to publication, Johannes Regenbogen for providing the yeast cDNA library, Gabi Stumpf and Lutz Zeitlmann for critical reading of the manuscript and E.-L.Winnacker for general support. This work was supported by grants from the BMBF, the DFG and the Genzentrum to M.M.

REFERENCES

1 Hanna-Rose,W. and Hansen,U. (1996) Trends Genet., 12, 29-243.

2 Auble,D.T., Hansen,K.E., Mueller,C.G., Lane,W.S., Thorner,J. and Hahn,S. (1994) Genes Dev., 8, 1920-1934. MEDLINE Abstract

3 Meisterernst,M. and Roeder,R.G. (1991) Cell, 83, 29-38.

4 Goppelt,A., Stelzer,G. and Meisterernst,M. (1996) EMBO J., 15, 3105-3116. MEDLINE Abstract

5 Mermelstein,F., Yeung,K., Cao,J., Inostroza,J.A., Erdjument-Bromage,H., Eagleson,K., Landsman,D., Levitt,P., Tempst,P. and Reinberg,D. (1996) Genes Dev., 10, 1033-1048. MEDLINE Abstract

6 Inostroza,J.A., Mermelstein,F.H., Ilho,H., Lane,W.S. and Reinberg,D. (1992) Cell, 70, 477-489. MEDLINE Abstract

7 Kim,T.K., Zhao,Y., Bernstein,R. and Roeder,R.G. (1995) J. Biol. Chem., 270, 10976-10981. MEDLINE Abstract

8 Geiger,J.H., Hahn,S., Lee,S. and Sigler,P.B. (1996) Science, 272, 830-836. MEDLINE Abstract

9 Tan,S., Hunziker,Y., Sargent,D.F. and Richmond, T.J. (1996) Nature (Lond.), 381, 127-134.

10 Bagby,S., Kim,S., Maldonado,E., Tong,K.I., Reinberg,D. and Ikura,M. (1995) Cell, 82, 857-867. MEDLINE Abstract

11 Nikolov,D.B., Chen,H., Halay,E.D., Usheva,A.A., Hisatake,K., Lee,D.K., Roeder,R.G. and Burley,S.K. (1995) Nature (Lond.), 377, 119-128.

12 Nikolov,D.B. and Burley,S.K. (1994) Nature Struct. Biol., 1, 621-637, and references therein.

13 Kretzschmar,M., Stelzer,G., Roeder,R.G. and Meisterernst,M. (1994) Mol. Cell. Biol., 14, 3927-3937. MEDLINE Abstract

14 Pruss,D., Hayes,J.J. and Wolffe,A.P. (1995) BioEssays, 17, 161-170. MEDLINE Abstract

15 Kuromori,T. and Yamamoto,M. (1994) Nucleic Acids Res., 22, 5296-301. MEDLINE Abstract

16 Yeung,K.C., Inostroza,J.A., Mermelstein,F.H., Kannarabin,C. and Reinberg,D. (1994) Genes Dev., 8, 2097-2109. MEDLINE Abstract

17 Arents,G. and Moudrianakis,E.N. (1995) Proc. Natl. Acad. Sci. USA, 92, 11170-11174. MEDLINE Abstract

18 Arents,G., Burlingame,R.W., Wang,B.-C., Love,W.E. and Moudrianakis,E.N. (1991) Proc. Natl. Acad. Sci. USA, 8, 10148-10152.

19 Arents,G. and Moudrianakis,E.N. (1993) Proc. Natl. Acad. Sci. USA, 90, 10489-10493. MEDLINE Abstract

20 Baxevanis,A.D., Arents,G., Moundrianakis,E.N. and Landsman,D. (1995) Nucleic Acids Res., 23, 2685-2691. MEDLINE Abstract

21 Kim,Y.-J., Bjorklund,S., Li,Y., Sayre,M.H. and Kornberg,R.D. (1994) Cell, 77, 599-608. MEDLINE Abstract

22 Koleske,A.J. and Young,R.A. (1994) Nature (Lond.), 368, 466-469.

23 Zhou,Q., Boyer,T.G. and Berk,A.J. (1993) Genes Dev., 7, 180-187. MEDLINE Abstract

24 Zhou,Q. and Berk,A.J. (1995) Mol. Cell. Biol., 15, 534-539. MEDLINE Abstract

25 Kelleher III,R.J., Flanagan,P.M., Chasman,D.I., Ponticelli,A.S., Struhl,K. and Kornberg,R.D. (1992) Genes Dev., 6, 296-303, and references therein.

26 Hahn,S., Buratowski,S., Sharp,P.A. and Guarente,L. (1989) EMBO J., 8, 3379-3382. MEDLINE Abstract

27 Ozer,J., Moore,P.A., Bolden,A.H., Lee,A., Rosen,C.A. and Lieberman,P.M. (1994) Genes Dev., 8, 2324-2335. MEDLINE Abstract

28 Ranish,J.A., Lane,W.S. and Hahn,S. (1992) Science, 255, 1127-1129. MEDLINE Abstract

29 Kim,I.-S., Sinha,S., de Crombrugghe,B. and Maity,S.N. (1996) Mol. Cell. Biol., 16, 4003-4013. MEDLINE Abstract

30 Sinha,S., Kim,I.-S., Sohn,K.-Y., de Crombrugghe,B. and Maity,S.N. (1996) Mol. Cell. Biol., 16, 328-337. MEDLINE Abstract

31 Elfring,L.K., Deuring,R., McCallum,C.M., Peterson,C.L. and Tamkun,J.W. (1994) Mol. Cell. Biol., 14, 2225-2234. MEDLINE Abstract

32 Hoffmann,A., Chiang,C.-M., Oelgeschläger,T., Xie,X., Burley,S.K., Nakatani,Y. and Roeder,R.G. (1996) Nature (Lond.), 380, 356-359.

33 Xie,X., Kokubo,T., Cohen, S.L., Mirza,U.A., Hoffmann,A., Chait,B.T., Roeder,R.G., Nakatani,Y. and Burley,S.K. (1996) Nature (Lond.), 380, 316-359.


Return

*To whom correspondence should be addressed. Tel: +49 89 74017 203; Fax: +49 89 74017 448; Email: meister@lmb.uni-muenchen.de
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
T. Kantidakis and R. J. White
Dr1 (NC2) is present at tRNA genes and represses their transcription in human cells
Nucleic Acids Res., December 3, 2009; (2009) gkp1102v1.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Peiro-Chova and F. Estruch
The Yeast RNA Polymerase II-associated Factor Iwr1p Is Involved in the Basal and Regulated Transcription of Specific Genes
J. Biol. Chem., October 16, 2009; 284(42): 28958 - 28967.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
N. Mohibullah and S. Hahn
Site-specific cross-linking of TBP in vivo and in vitro reveals a direct functional interaction with the SAGA subunit Spt3
Genes & Dev., November 1, 2008; 22(21): 2994 - 3006.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Malecova, P. Gross, M. Boyer-Guittaut, S. Yavuz, and T. Oelgeschlager
The Initiator Core Promoter Element Antagonizes Repression of TATA-directed Transcription by Negative Cofactor NC2
J. Biol. Chem., August 24, 2007; 282(34): 24767 - 24776.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Takagi and R. D. Kornberg
Mediator as a General Transcription Factor
J. Biol. Chem., January 6, 2006; 281(1): 80 - 89.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Gulshan, S. A. Rovinsky, S. T. Coleman, and W. S. Moye-Rowley
Oxidant-specific Folding of Yap1p Regulates Both Transcriptional Activation and Nuclear Localization
J. Biol. Chem., December 9, 2005; 280(49): 40524 - 40533.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Nair, Y. Kim, and L. C. Myers
Mediator and TFIIH Govern Carboxyl-terminal Domain-dependent Transcription in Yeast Extracts
J. Biol. Chem., October 7, 2005; 280(40): 33739 - 33748.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Gilfillan, G. Stelzer, E. Piaia, M. G. Hofmann, and M. Meisterernst
Efficient Binding of NC2{middle dot}TATA-binding Protein to DNA in the Absence of TATA
J. Biol. Chem., February 18, 2005; 280(7): 6222 - 6230.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. P. Klejman, L. A. Pereira, H. J. T. van Zeeburg, S. Gilfillan, M. Meisterernst, and H. T. M. Timmers
NC2{alpha} Interacts with BTAF1 and Stimulates Its ATP-Dependent Association with TATA-Binding Protein
Mol. Cell. Biol., November 15, 2004; 24(22): 10072 - 10082.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Takahata, H. Ryu, K. Ohtsuki, K. Kasahara, M. Kawaichi, and T. Kokubo
Identification of a Novel TATA Element-binding Protein Binding Region at the N Terminus of the Saccharomyces cerevisiae TAF1 Protein
J. Biol. Chem., November 14, 2003; 278(46): 45888 - 45902.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Escobar-Henriques, B. Daignan-Fornier, and M. A. Collart
The Critical cis-Acting Element Required for IMD2 Feedback Regulation by GDP Is a TATA Box Located 202 Nucleotides Upstream of the Transcription Start Site
Mol. Cell. Biol., September 1, 2003; 23(17): 6267 - 6278.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H. Kou, J. D. Irvin, K. L. Huisinga, M. Mitra, and B. F. Pugh
Structural and Functional Analysis of Mutations along the Crystallographic Dimer Interface of the Yeast TATA Binding Protein
Mol. Cell. Biol., May 1, 2003; 23(9): 3186 - 3201.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
F. Estruch and C. N. Cole
An Early Function during Transcription for the Yeast mRNA Export Factor Dbp5p/Rat8p Suggested by Its Genetic and Physical Interactions with Transcription Factor IIH Components
Mol. Biol. Cell, April 1, 2003; 14(4): 1664 - 1676.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
S. Creton, J. Q. Svejstrup, and M. A. Collart
The NC2 alpha and beta subunits play different roles in vivo
Genes & Dev., December 15, 2002; 16(24): 3265 - 3276.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Cang and G. Prelich
Direct stimulation of transcription by negative cofactor 2 (NC2) through TATA-binding protein (TBP)
PNAS, October 1, 2002; 99(20): 12727 - 12732.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
M. Lee and K. Struhl
Multiple Functions of the Nonconserved N-Terminal Domain of Yeast TATA-Binding Protein
Genetics, May 1, 2001; 158(1): 87 - 93.
[Abstract] [Full Text]


Home page
GeneticsHome page
V. Badarinarayana, Y.-C. Chiang, and C. L. Denis
Functional Interaction of CCR4-NOT Proteins With TATAA-Binding Protein (TBP) and Its Associated Factors in Yeast
Genetics, July 1, 2000; 155(3): 1045 - 1054.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
S. Kim, K. Cabane, M. Hampsey, and D. Reinberg
Genetic Analysis of the Ydr1-Bur6 Repressor Complex Reveals an Intricate Balance among Transcriptional Regulatory Proteins in Yeast
Mol. Cell. Biol., April 1, 2000; 20(7): 2455 - 2465.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
T. I. Lee, J. J. Wyrick, S. S. Koh, E. G. Jennings, E. L. Gadbois, and R. A. Young
Interplay of Positive and Negative Regulators in Transcription Initiation by RNA Polymerase II Holoenzyme
Mol. Cell. Biol., August 1, 1998; 18(8): 4455 - 4462.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
N. Kobayashi, P. J. Horn, S. M. Sullivan, S. J. Triezenberg, T. G. Boyer, and A. J. Berk
DA-Complex Assembly Activity Required for VP16C Transcriptional Activation
Mol. Cell. Biol., July 1, 1998; 18(7): 4023 - 4031.
[Abstract] [Full Text]


Home page
Microbiol. Mol. Biol. Rev.Home page
M. Hampsey
Molecular Genetics of the RNA Polymerase II General Transcriptional Machinery
Microbiol. Mol. Biol. Rev., June 1, 1998; 62(2): 465 - 503.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
T. I. Lee and R. A. Young
Regulation of gene expression by TBP-associated proteins
Genes & Dev., May 15, 1998; 12(10): 1398 - 1408.
[Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. L. Gadbois, D. M. Chao, J. C. Reese, M. R. Green, and R. A. Young
Functional antagonism between RNA polymerase II holoenzyme and global negative regulator NC2  in vivo
PNAS, April 1, 1997; 94(7): 3145 - 3150.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. I. Adamkewicz, C. G. F. Mueller, K. E. Hansen, W. A. Prud'homme, and J. Thorner
Purification and Enzymic Properties of Mot1 ATPase, a Regulator of Basal Transcription in the Yeast Saccharomyces cerevisiae
J. Biol. Chem., July 7, 2000; 275(28): 21158 - 21168.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Print PDF (155K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (33)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Goppelt, A
Right arrow Articles by Meisterernst, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goppelt, A
Right arrow Articles by Meisterernst, M
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?